Cargando…

PET imaging of [(11)C]PBR28 in Parkinson’s disease patients does not indicate increased binding to TSPO despite reduced dopamine transporter binding

PURPOSE: To examine the hypothesis that cerebral binding to the 18 kDa translocator protein (TSPO), a marker of microglia activation, is elevated in Parkinson’s disease (PD), and to assess the relationship between brain TSPO binding and dopaminergic pathology in PD. METHODS: The radioligand [(11)C]P...

Descripción completa

Detalles Bibliográficos
Autores principales:	Varnäs, Katarina, Cselényi, Zsolt, Jucaite, Aurelija, Halldin, Christer, Svenningsson, Per, Farde, Lars, Varrone, Andrea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333720/ https://www.ncbi.nlm.nih.gov/pubmed/30270409 http://dx.doi.org/10.1007/s00259-018-4161-6

Ejemplares similares

Kinetic analysis and test-retest variability of the radioligand [(11)C](R)-PK11195 binding to TSPO in the human brain - a PET study in control subjects
por: Jučaite, Aurelija, et al.
Publicado: (2012)

GABA(A) receptor occupancy by subtype selective GABA(Aα2,3) modulators: PET studies in humans
por: Jucaite, Aurelija, et al.
Publicado: (2016)

Effects of age, BMI and sex on the glial cell marker TSPO — a multicentre [(11)C]PBR28 HRRT PET study
por: Tuisku, Jouni, et al.
Publicado: (2019)

Quantification and reliability of [(11)C]VC - 002 binding to muscarinic acetylcholine receptors in the human lung — a test-retest PET study in control subjects
por: Cselényi, Zsolt, et al.
Publicado: (2020)

Glia Imaging Shows Clinical Utility in Differentiating Parkinson's Disease from Multiple System Atrophy
por: Rinne, Juha O., et al.
Publicado: (2022)

Comparison of D(2) dopamine receptor occupancy after oral administration of quetiapine fumarate immediate-release and extended-release formulations in healthy subjects
por: Nord, Magdalena, et al.
Publicado: (2011)

Influence of alcoholism and cholesterol on TSPO binding in brain: PET [(11)C]PBR28 studies in humans and rodents
por: Kim, Sung Won, et al.
Publicado: (2018)

An 18-kDa Translocator Protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28
por: Owen, David R, et al.
Publicado: (2012)

Assessment of simplified ratio-based approaches for quantification of PET [(11)C]PBR28 data
por: Matheson, Granville J., et al.
Publicado: (2017)

Decreased 5‐HT(1A) binding in mild Alzheimer's disease—A positron emission tomography study
por: Mattsson, Patrik, et al.
Publicado: (2022)

PET Evaluation of the Novel F-18 Labeled Reversible Radioligand [(18)F]GEH200449 for Detection of Monoamine Oxidase-B in the Non-Human Primate Brain
por: Varnäs, Katarina, et al.
Publicado: (2023)

Test-retest reliability and convergent validity of (R)-[(11)C]PK11195 outcome measures without arterial input function
por: Plavén-Sigray, Pontus, et al.
Publicado: (2018)

Serotonin 1B receptor density mapping of the human brainstem using positron emission tomography and autoradiography
por: Veldman, Emma R, et al.
Publicado: (2021)

High-resolution PET imaging reveals subtle impairment of the serotonin transporter in an early non-depressed Parkinson’s disease cohort
por: Fazio, Patrik, et al.
Publicado: (2020)

Positron Emission Tomography studies with [(11)C]PBR28 in the Healthy Rodent Brain: Validating SUV as an Outcome Measure of Neuroinflammation
por: Tóth, Miklós, et al.
Publicado: (2015)

Effects of sevoflurane anaesthesia on radioligand binding to monoamine oxidase-B in vivo
por: Varnäs, Katarina, et al.
Publicado: (2021)

Detection of amyloid in Alzheimer’s disease with positron emission tomography using [(11)C]AZD2184
por: Nyberg, Svante, et al.
Publicado: (2009)

Pulmonary PET imaging confirms preferential lung target occupancy of an inhaled bronchodilator
por: Schou, Magnus, et al.
Publicado: (2019)

Low background and high contrast PET imaging of amyloid-β with [(11)C]AZD2995 and [(11)C]AZD2184 in Alzheimer’s disease patients
por: Forsberg, Anton, et al.
Publicado: (2013)

Brain exposure of osimertinib in patients with epidermal growth factor receptor mutation non‐small cell lung cancer and brain metastases: A positron emission tomography and magnetic resonance imaging study
por: Ekman, Simon, et al.
Publicado: (2023)

Reliability of dopamine transporter PET measurements with [(18)F]FE-PE2I in patients with Parkinson’s disease
por: Kerstens, Vera S., et al.
Publicado: (2020)

[(11)C]SCH23390 binding to the D(1)-dopamine receptor in the human brain—a comparison of manual and automated methods for image analysis
por: Stenkrona, Per, et al.
Publicado: (2018)

Amphetamine Decreases α(2C)-Adrenoceptor Binding of [(11)C]ORM-13070: A PET Study in the Primate Brain
por: Finnema, Sjoerd J, et al.
Publicado: (2015)

Simplified quantification of [(18)F]FE-PE2I PET in Parkinson’s disease: Discriminative power, test–retest reliability and longitudinal validity during early peak and late pseudo-equilibrium
por: Brumberg, Joachim, et al.
Publicado: (2020)

Synthesis and Characterization of a “Clickable” PBR28 TSPO-Selective Ligand Derivative Suitable for the Functionalization of Biodegradable Polymer Nanoparticles
por: Auriemma, Renato, et al.
Publicado: (2021)

Synthesis, Biodistribution, and Radiation Dosimetry of a Novel mGluR5 Radioligand: (18)F-AZD9272
por: Nag, Sangram, et al.
Publicado: (2020)

[(18)F]FE-PE2I DAT correlates with Parkinson’s disease duration, stage, and rigidity/bradykinesia scores: a PET radioligand validation study
por: Kerstens, Vera S., et al.
Publicado: (2023)

Large Variation in Brain Exposure of Reference CNS Drugs: a PET Study in Nonhuman Primates
por: Schou, Magnus, et al.
Publicado: (2015)

Positron emission tomography and functional characterization of a complete PBR/TSPO knockout
por: Banati, Richard B., et al.
Publicado: (2014)

The Comprehensive Steroidome in Complete TSPO/PBR Knockout Mice under Basal Conditions
por: Liere, Philippe, et al.
Publicado: (2023)

D1-Dopamine Receptor Availability in First-Episode Neuroleptic Naive Psychosis Patients
por: Stenkrona, Per, et al.
Publicado: (2019)

Neurokinin-3 Receptor Binding in Guinea Pig, Monkey, and Human Brain: In Vitro and in Vivo Imaging Using the Novel Radioligand, [(18)F]Lu AF10628
por: Varnäs, Katarina, et al.
Publicado: (2016)

[(11)C]PBR28 MR–PET imaging reveals lower regional brain expression of translocator protein (TSPO) in young adult males with autism spectrum disorder
por: Zürcher, N. R., et al.
Publicado: (2020)

A randomized placebo-controlled PET study of ketamine´s effect on serotonin(1B) receptor binding in patients with SSRI-resistant depression
por: Tiger, Mikael, et al.
Publicado: (2020)

Synthesis and Autoradiography of Novel F-18 Labeled Reversible Radioligands for Detection of Monoamine Oxidase B
por: Nag, Sangram, et al.
Publicado: (2020)

An In Vivo Study of a Rat Fluid-Percussion-Induced Traumatic Brain Injury Model with [(11)C]PBR28 and [(18)F]flumazenil PET Imaging
por: Ghosh, Krishna Kanta, et al.
Publicado: (2021)

In vivo TSPO imaging in patients with multiple sclerosis: a brain PET study with [(18)F]FEDAA1106
por: Takano, Akihiro, et al.
Publicado: (2013)

Neuroinflammation in frontotemporal lobar degeneration revealed by (11)C‐PBR28 PET
por: Kim, Min-Jeong, et al.
Publicado: (2019)

Improved Automated Radiosynthesis of [(11)C]PBR28
por: Solingapuram Sai, Kiran Kumar, et al.
Publicado: (2015)

Is dopamine D1 receptor availability related to social behavior? A positron emission tomography replication study
por: Plavén-Sigray, Pontus, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_oefg26clr2u23eh8jb4nuluunv